Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Deferred Taxes (2021 - 2025)

Historic Deferred Taxes for Definitive Healthcare (DH) over the last 5 years, with Q3 2025 value amounting to -$299000.0.

  • Definitive Healthcare's Deferred Taxes fell 10217.08% to -$299000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $16.4 million, marking a year-over-year decrease of 5400.63%. This contributed to the annual value of $42.7 million for FY2024, which is 12802.33% up from last year.
  • As of Q3 2025, Definitive Healthcare's Deferred Taxes stood at -$299000.0, which was down 10217.08% from -$398000.0 recorded in Q2 2025.
  • In the past 5 years, Definitive Healthcare's Deferred Taxes ranged from a high of $22.0 million in Q2 2024 and a low of -$1.0 million during Q4 2023
  • Moreover, its 5-year median value for Deferred Taxes was $810000.0 (2023), whereas its average is $5.6 million.
  • Over the last 5 years, Definitive Healthcare's Deferred Taxes had its largest YoY gain of 4110000.0% in 2023, and its largest YoY loss of 10594.02% in 2023.
  • Quarter analysis of 5 years shows Definitive Healthcare's Deferred Taxes stood at $436000.0 in 2021, then surged by 3819.04% to $17.1 million in 2022, then tumbled by 105.94% to -$1.0 million in 2023, then surged by 697.14% to $6.1 million in 2024, then plummeted by 104.93% to -$299000.0 in 2025.
  • Its Deferred Taxes stands at -$299000.0 for Q3 2025, versus -$398000.0 for Q2 2025 and $11.0 million for Q1 2025.